Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression - PubMed (original) (raw)
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression
Robert J Scheubel et al. J Am Coll Cardiol. 2002.
Free article
Abstract
Objectives: Activity of mitochondrial respiratory chain complexes with and without mitochondrially encoded subunits was assessed in failing human myocardium together with parameters of mitochondrial gene expression.
Background: Mutations and deletions in mitochondrial genome (mtDNA) sporadically accumulate in the aging myocardium. In experimental heart failure, they are discussed to be a generalized problem resulting in disturbances of mitochondrial gene expression and mitochondrial function.
Methods: In left ventricular specimens from 43 explanted failing hearts and 10 donor hearts, enzyme activities of respiratory chain complexes, messenger ribonucleic acid (mRNA) expression of mitochondrially and nuclear encoded mitochondrial components (reverse transcriptase-polymerase chain reaction, Northern blot), undeleted wildtype mtDNA (Southern blot), and nuclear encoded mitochondrial transcription factor A (mtTFA) (Western blot) were quantified.
Results: Citrate synthase normalized activity of mitochondrial respiratory chain complex I, which contains seven mitochondrially encoded subunits, was decreased by 28% in terminally failing myocardium, whereas the activity of the exclusively nuclear encoded complex II was unchanged. However, the amount of intact mtDNA, the mRNA of all mitochondrially encoded subunits of the entire respiratory chain, the amount of mtTFA, and the enzymatic activity of complex III and complex IV, which also contain mitochondrially encoded subunits, were normal compared with donor hearts, excluding generalized disturbance of mitochondrial gene expression. Retrospective analysis of drug therapy before transplantation identified beta-blockers as one putative protection against this disturbance.
Conclusions: In terminally failing human myocardium of patients receiving drug therapy, complex I depression is not caused by mtDNA damage and disturbed mitochondrial gene expression. The absence of mtDNA damage should facilitate recovery of the overloaded myocardium, if effective unloading could be achieved.
Comment in
- Mitochondrial dysfunction in heart failure.
Marin-Garcia J. Marin-Garcia J. J Am Coll Cardiol. 2003 Jun 18;41(12):2299; author reply 2299. doi: 10.1016/s0735-1097(03)00494-7. J Am Coll Cardiol. 2003. PMID: 12821264 No abstract available.
Similar articles
- Mitochondrial gene expression is impaired by ethanol exposure in cultured chick cardiac myocytes.
Kennedy JM. Kennedy JM. Cardiovasc Res. 1998 Jan;37(1):141-50. doi: 10.1016/s0008-6363(97)00198-3. Cardiovasc Res. 1998. PMID: 9539868 - Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin.
Lebrecht D, Kokkori A, Ketelsen UP, Setzer B, Walker UA. Lebrecht D, et al. J Pathol. 2005 Dec;207(4):436-44. doi: 10.1002/path.1863. J Pathol. 2005. PMID: 16278810 - Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction.
Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, Takeshita A. Ide T, et al. Circ Res. 2001 Mar 16;88(5):529-35. doi: 10.1161/01.res.88.5.529. Circ Res. 2001. PMID: 11249877 - Mitochondrial-nuclear cross-talk in the aging and failing heart.
Marín-García J, Pi Y, Goldenthal MJ. Marín-García J, et al. Cardiovasc Drugs Ther. 2006 Dec;20(6):477-91. doi: 10.1007/s10557-006-0584-6. Cardiovasc Drugs Ther. 2006. PMID: 17119872 Review. - Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
Tsutsui H, Kinugawa S, Matsushima S. Tsutsui H, et al. Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854381 Review.
Cited by
- ECSIT is a critical limiting factor for cardiac function.
Xu L, Humphries F, Delagic N, Wang B, Holland A, Edgar KS, Hombrebueno JR, Stolz DB, Oleszycka E, Rodgers AM, Glezeva N, McDonald K, Watson CJ, Ledwidge MT, Ingram RJ, Grieve DJ, Moynagh PN. Xu L, et al. JCI Insight. 2021 Jun 22;6(12):e142801. doi: 10.1172/jci.insight.142801. JCI Insight. 2021. PMID: 34032637 Free PMC article. - Energetics and metabolism in the failing heart: important but poorly understood.
Turer AT, Malloy CR, Newgard CB, Podgoreanu MV. Turer AT, et al. Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):458-65. doi: 10.1097/MCO.0b013e32833a55a5. Curr Opin Clin Nutr Metab Care. 2010. PMID: 20453645 Free PMC article. Review. - CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.
Mosqueira D, Mannhardt I, Bhagwan JR, Lis-Slimak K, Katili P, Scott E, Hassan M, Prondzynski M, Harmer SC, Tinker A, Smith JGW, Carrier L, Williams PM, Gaffney D, Eschenhagen T, Hansen A, Denning C. Mosqueira D, et al. Eur Heart J. 2018 Nov 14;39(43):3879-3892. doi: 10.1093/eurheartj/ehy249. Eur Heart J. 2018. PMID: 29741611 Free PMC article. - Study of respiratory chain dysfunction in heart disease.
Hassanpour SH, Dehghani MA, Karami SZ. Hassanpour SH, et al. J Cardiovasc Thorac Res. 2018;10(1):1-13. doi: 10.15171/jcvtr.2018.01. Epub 2018 Mar 17. J Cardiovasc Thorac Res. 2018. PMID: 29707171 Free PMC article. Review. - Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failure.
Wu SP, Kao CY, Wang L, Creighton CJ, Yang J, Donti TR, Harmancey R, Vasquez HG, Graham BH, Bellen HJ, Taegtmeyer H, Chang CP, Tsai MJ, Tsai SY. Wu SP, et al. Nat Commun. 2015 Sep 10;6:8245. doi: 10.1038/ncomms9245. Nat Commun. 2015. PMID: 26356605 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources